MedPath

Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age

Phase 2
Completed
Conditions
Dental Caries in Children
Interventions
Registration Number
NCT05670743
Lead Sponsor
Advantage Silver Dental Arrest, LLC
Brief Summary

The purpose of this study is to further characterize basic pharmacokinetic (PK) parameters in healthy children to contribute to evidence for the safety of silver diamine fluoride (SDF; Advantage Arrest). Children with at least one active cavity will be treated and then have blood draws at random time points afterwards.

Detailed Description

The FDA requested additional data to evaluate the pharmacokinetics of silver diamine fluoride (SDF, Advantage Arrest) in children 13 months to 13 years old. The first request is for children under 36 months of age to be included in a study. The second request is for serum silver concentration be evaluated for a longer duration post-application to better estimate the half-life of silver and return of serum silver to baseline levels in children.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • At least one untreated caries lesion into the dentin
  • Live within 10 miles of study site
Exclusion Criteria
  • oral mucositis
  • ulcerative oral lesions
  • hypersensitivity to silver or fluoride
  • history of treatment with silver diamine fluoride within 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Silver diamine fluoride38% silver diamine fluorideSilver diamine fluoride, 38%, topical, single application
Primary Outcome Measures
NameTimeMethod
Fluoride Cmax21 days

Maximum serum concentration of fluoride

Fluoride Tmax21 days

Time to maximum serum concentration of fluoride

Area Under Curve, Fluoride21 days

Area under the curve, fluoride

Area Under Curve, Silver21 days

Area under the curve, silver

Silver Cmax21 days

Maximum serum concentration of silver

Silver Tmax21 days

Time to maximum serum concentration of silver

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Pediatric Dentistry

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath